Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Digital Transformation Leads to New Growth Strategies for Stakeholders
* Required Fields
Pay by invoice
The global COVID-19 pandemic and other geo-political events left many businesses facing an unprecedented state of uncertainty. Healthcare companies across the care continuum remain grappling with these new challenges, of which the extent and longevity remain unknown. Spurred by the year’s events, healthcare delivery has accelerated its transformation, and the concept of anytime-anywhere care has taken course to become mainstream. Digital health applications—especially telehealth and remote patient monitoring—saw tremendous demand as the only means to continue care delivery for many during the pandemic. To align with the new normal, vendors will need to redefine their visions and strategies, ensuring they are ready to tackle 2021 and beyond. Use of artificial intelligence (AI) across the spectrum of applications, cloud computing, patient engagement solutions, and home monitoring represent strong opportunities for growth. The new vision for healthcare in 2021 will focus on access, quality, and affordability, in addition to strategies designed to overcome the losses sustained in 2020, while ensuring healthcare remains precise, preventive, and outcome-based in the promotion of social and financial inclusion.
This study covers aspects of the global healthcare industry that develop and provide products, solutions, and/or services across the care spectrum for diagnosis, treatment, and prevention. Key sectors considered in the study scope are pharmaceuticals and biotechnology (pharma & biotech); in-vitro diagnostics (IVD); advanced medical technologies; medical imaging and informatics; and digital health. The study period is 2019 to 2025 using a base year of 2020.
The 2021 Outlook concludes with a discussion of five growth opportunities identified by Frost & Sullivan as the major areas where competitors in this space must take action.
Author: Chandni Mathur
Global Orthopedics Growth Opportunities
GROWTH OPPORTUNITIES IN SYNTHETIC BIOLOGY, AI AUGMENTED DIAGNOSTICS, MICROBIOME ENABLERS, BIOMARKER DISCOVERY, AND LAB AUTOMATION
US Chronic Disease Management Growth Opportunities
Global Neurological Therapies Growth Opportunities
Global Structural Heart Devices Growth Opportunities
Global Healthcare Cloud Growth Opportunities
INNOVATIONS AND GROWTH OPPORTUNITIES IN ORGAN PERFUSION AND PRESERVATION, DIGITAL THERAPEUTICS, AND WOUND ANALYSIS PLATFORMS
GROWTH OPPORTUNITIES IN PLATFORM TECHNOLOGIES, DIAGNOSTICS, AND ADVANCED THERAPEUTICS
Global Renal Care Management Growth Opportunities
augmented reality market
functional food market
commercial lighting market
heavy commercial vehicles market
power electronics market
fuel cell market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.